Airsculpt Technologies Inc
$ 5.38
-2.89%
29 May - close price
- Market Cap 379,536,000 USD
- Current Price $ 5.38
- High / Low $ 5.58 / 5.29
- Stock P/E N/A
- Book Value 1.42
- EPS -0.17
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -0.13 %
- 52 Week High 12.00
- 52 Week Low 1.51
About
Airsculpt Technologies Inc (AIRS) is a pioneering company in the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure that delivers minimally invasive body contouring with a strong commitment to patient safety and comfort. The company is strategically expanding its network of licensed practitioners, supported by a robust focus on technological advancements, which positions Airsculpt favorably within the rapidly growing non-invasive cosmetic treatment market. As consumer demand for aesthetic solutions continues to rise globally, Airsculpt is well-positioned to enhance its market share and diversify its service offerings, aiming to achieve substantial growth and sustainable value for its investors.
Analyst Target Price
$4.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-02 | 2026-03-06 | 2025-11-07 | 2025-08-01 | 2025-05-02 | 2025-03-14 | 2024-11-08 | 2024-08-09 | 2024-05-10 | 2024-02-27 | 2023-11-09 | 2023-08-11 |
| Reported EPS | 0.0199 | -0.02 | -0.15 | -0.01 | -0.02 | -0.08 | -0.1 | -0.06 | 0.1 | -0.08 | -0.03 | 0.03 |
| Estimated EPS | -0.0204 | -0.0286 | -0.02 | 0.01 | -0.0333 | 0.0167 | -0.05 | 0.04 | -0.02 | 0.02 | -0.02 | 0.05 |
| Surprise | 0.0403 | 0.0086 | -0.13 | -0.02 | 0.0133 | -0.0967 | -0.05 | -0.1 | 0.12 | -0.1 | -0.01 | -0.02 |
| Surprise Percentage | 197.549% | 30.0699% | -650% | -200% | 39.9399% | -579.0419% | -100% | -250% | 600% | -500% | -50% | -40% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.41 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AIRS
2026-05-28 06:38:54
AirSculpt Technologies, Inc. (NASDAQ: AIRS) announced its participation in two upcoming investor conferences in June 2026. Management will attend the William Blair 46th Annual Growth Stock Conference and the Jefferies Global Healthcare Conference to conduct one-on-one meetings with investors.
2026-05-27 20:09:40
AirSculpt Technologies (NASDAQ:AIRS) announced its participation in two investor conferences in June 2026: the TD Cowen 10th Annual Future of the Consumer Conference and the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference. Management plans to present and engage in investor meetings at both events, with fireside chats webcast live and available for replay. The company specializes in minimally invasive body contouring procedures.
2026-05-27 17:09:58
AirSculpt Technologies, Inc. (NASDAQ: AIRS) announced its participation in two upcoming investor conferences: the TD Cowen 10th Annual Future of the Consumer Conference on June 3, 2026, and the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on June 9, 2026. The company's management will host fireside chats and investor meetings at both events, with live and replay options available on their investor relations website. AirSculpt specializes in premium body contouring procedures.
2026-05-21 00:09:30
EBS Aggregator Blocker Holdings, LLC, an entity associated with major Airsculpt (AIRS) holder Adam T. Feinstein, disclosed an in-kind distribution of 5,169,820 common shares. This transaction, made to Thrivent White Rose Fund XI Equity Direct, L.P. for no consideration, was conducted under a pre-existing letter agreement, and was classified as an "other" type transaction rather than a market purchase or sale. Following this activity, indirect holdings across related entities were updated.
2026-05-20 03:08:59
AirSculpt Technologies has returned to positive same-store sales growth after over two years of declines, driven by optimized marketing strategies. The company sees a significant growth opportunity in addressing aesthetic side effects like loose skin and stubborn fat deposits for GLP-1 weight-loss drug users. AirSculpt plans to expand its service offerings, including skin tightening and removal, and potentially add another 100 U.S. clinics, while having reduced debt and refreshed its executive team.
2026-05-20 01:39:45
This article provides a stock quote for AirSculpt Technologies, Inc. (NASDAQ:AIRS), showing its current trading price, volume, and performance metrics. It also includes recent news headlines about the company's Q1 earnings, sales rebound with GLP-1 tailwind for body contouring growth, and previous financial reports and analyst insights. The information covers detailed quote data, historical prices, and frequently asked questions about the stock.
